# Tanger Inc.: financial statements, quarterly

SKT · NYSE · CIK 899715 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/skt.md) · [Financials](/companies/skt/financials.md) · [Filings](/companies/skt/filings.md) · [Insiders](/companies/skt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/skt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [111](/filings/0000899715-23-000157.md) | [109](/filings/0000899715-24-000096.md) | [111](/filings/0000899715-24-000119.md) | [117](/filings/0000899715-24-000145.md) | [123](/filings/0000899715-25-000106.md) | [129](/filings/0000899715-25-000125.md) | [133](/filings/0001628280-25-050139.md) | [135](/filings/0001628280-26-029536.md) | [141](/filings/0001628280-26-053864.md) | [145](/filings/0001628280-25-050139.md) | [139](/filings/0001628280-26-029536.md) | [144](/filings/0001628280-26-053864.md) |
| Interest expense | $m | [11.7](/filings/0000899715-23-000157.md) | [12.3](/filings/0000899715-24-000096.md) | [12.0](/filings/0000899715-24-000119.md) | [11.7](/filings/0000899715-23-000157.md) | [14.4](/filings/0000899715-24-000096.md) | [15.7](/filings/0000899715-24-000119.md) | [15.5](/filings/0001628280-25-050139.md) | [15.8](/filings/0001628280-26-029536.md) | [16.4](/filings/0001628280-26-053864.md) | [16.4](/filings/0001628280-25-050139.md) | [19.2](/filings/0001628280-26-029536.md) | [19.4](/filings/0001628280-26-053864.md) |
| Net income | $m | [23.3](/filings/0000899715-23-000157.md) | [23.5](/filings/0000899715-24-000096.md) | [24.2](/filings/0000899715-24-000119.md) | [27.6](/filings/0000899715-24-000145.md) | [22.4](/filings/0000899715-25-000106.md) | [24.8](/filings/0000899715-25-000125.md) | [24.9](/filings/0001628280-25-050139.md) | [19.2](/filings/0001628280-26-029536.md) | [30.1](/filings/0001628280-26-053864.md) | [32.0](/filings/0001628280-25-050139.md) | [28.3](/filings/0001628280-26-029536.md) | [33.2](/filings/0001628280-26-053864.md) |
| Diluted EPS | $ per share | [0.22](/filings/0000899715-23-000157.md) | [0.22](/filings/0000899715-24-000096.md) | [0.23](/filings/0000899715-24-000119.md) | [0.26](/filings/0000899715-24-000145.md) | [0.20](/filings/0000899715-25-000106.md) | [0.22](/filings/0000899715-25-000125.md) | [0.22](/filings/0001628280-25-050139.md) | [0.17](/filings/0001628280-26-029536.md) | [0.26](/filings/0001628280-26-053864.md) | [0.28](/filings/0001628280-25-050139.md) | [0.24](/filings/0001628280-26-029536.md) | [0.29](/filings/0001628280-26-053864.md) |
| Basic EPS | $ per share | [0.22](/filings/0000899715-23-000157.md) | [0.22](/filings/0000899715-24-000096.md) | [0.23](/filings/0000899715-24-000119.md) | [0.26](/filings/0000899715-24-000145.md) | [0.20](/filings/0000899715-25-000106.md) | [0.23](/filings/0000899715-25-000125.md) | [0.23](/filings/0001628280-25-050139.md) | [0.17](/filings/0001628280-26-029536.md) | [0.27](/filings/0001628280-26-053864.md) | [0.28](/filings/0001628280-25-050139.md) | [0.25](/filings/0001628280-26-029536.md) | [0.29](/filings/0001628280-26-053864.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [188](/filings/0000899715-23-000157.md) | [12.8](/filings/0001628280-26-012252.md) | [8.1](/filings/0000899715-24-000096.md) | [9.1](/filings/0000899715-24-000119.md) | [11.1](/filings/0001628280-25-050139.md) | [47.0](/filings/0001628280-26-053864.md) | [10.2](/filings/0001628280-26-029536.md) | [9.7](/filings/0001628280-26-053864.md) | [13.0](/filings/0001628280-25-050139.md) | [18.1](/filings/0001628280-26-053864.md) | [207](/filings/0001628280-26-029536.md) | [177](/filings/0001628280-26-053864.md) |
| Total assets | $m | [2,205](/filings/0000899715-23-000157.md) | [2,324](/filings/0000899715-24-000145.md) | [2,301](/filings/0000899715-24-000096.md) | [2,294](/filings/0000899715-24-000119.md) | [2,275](/filings/0000899715-24-000145.md) | [2,381](/filings/0001628280-25-050139.md) | [2,478](/filings/0000899715-25-000106.md) | [2,452](/filings/0000899715-25-000125.md) | [2,636](/filings/0001628280-25-050139.md) | [2,656](/filings/0001628280-26-053864.md) | [2,834](/filings/0001628280-26-029536.md) | [2,860](/filings/0001628280-26-053864.md) |
| Total liabilities | $m | [1,693](/filings/0000899715-23-000157.md) | [1,733](/filings/0000899715-24-000145.md) | [1,721](/filings/0000899715-24-000096.md) | [1,716](/filings/0000899715-24-000119.md) | [1,683](/filings/0000899715-24-000145.md) | [1,702](/filings/0001628280-25-050139.md) | [1,818](/filings/0000899715-25-000106.md) | [1,791](/filings/0000899715-25-000125.md) | [1,904](/filings/0001628280-25-050139.md) | [1,921](/filings/0001628280-26-053864.md) | [2,136](/filings/0001628280-26-029536.md) | [2,158](/filings/0001628280-26-053864.md) |
| Long-term debt | $m | [1,427](/filings/0000899715-23-000157.md) | [1,439](/filings/0000899715-24-000145.md) | [1,472](/filings/0000899715-24-000096.md) | [1,460](/filings/0000899715-24-000119.md) | [1,424](/filings/0000899715-24-000145.md) | [1,424](/filings/0001628280-25-050139.md) | [1,563](/filings/0000899715-25-000106.md) | [1,526](/filings/0000899715-25-000125.md) | [1,613](/filings/0001628280-25-050139.md) | [1,597](/filings/0001628280-26-053864.md) | [1,866](/filings/0001628280-26-029536.md) | [1,861](/filings/0001628280-26-053864.md) |
| Shareholders' equity | $m | [491](/filings/0000899715-23-000157.md) | [567](/filings/0000899715-24-000145.md) | [556](/filings/0000899715-24-000096.md) | [554](/filings/0000899715-24-000119.md) | [568](/filings/0000899715-24-000145.md) | [652](/filings/0001628280-25-050139.md) | [634](/filings/0000899715-25-000106.md) | [635](/filings/0000899715-25-000125.md) | [704](/filings/0001628280-25-050139.md) | [706](/filings/0001628280-26-053864.md) | [670](/filings/0001628280-26-029536.md) | [674](/filings/0001628280-26-053864.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [33.7 d](/filings/0000899715-23-000157.md) | [25.6](/filings/0000899715-24-000096.md) | [73.3 d](/filings/0000899715-24-000119.md) | [53.2 d](/filings/0000899715-24-000145.md) | [31.1](/filings/0000899715-25-000106.md) | [72.8 d](/filings/0000899715-25-000125.md) | [65.2 d](/filings/0001628280-25-050139.md) | [41.4](/filings/0001628280-26-029536.md) | [82.0 d](/filings/0001628280-26-053864.md) | [74.3 d](/filings/0001628280-25-050139.md) | [36.3](/filings/0001628280-26-029536.md) | [93.5 d](/filings/0001628280-26-053864.md) |
| Dividends paid | $m | [20.9 d](/filings/0000899715-23-000157.md) | [24.6](/filings/0000899715-24-000096.md) | [25.8 d](/filings/0000899715-24-000119.md) | [25.8 d](/filings/0000899715-24-000145.md) | [29.6](/filings/0000899715-25-000106.md) | [30.1 d](/filings/0000899715-25-000125.md) | [30.1 d](/filings/0001628280-25-050139.md) | [32.2](/filings/0001628280-26-029536.md) | [33.1 d](/filings/0001628280-26-053864.md) | [33.1 d](/filings/0001628280-25-050139.md) | [35.0](/filings/0001628280-26-029536.md) | [35.9 d](/filings/0001628280-26-053864.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-029536.md) | [0.0 d](/filings/0001628280-26-053864.md) | not reported | [20.0](/filings/0001628280-26-029536.md) | [0.0 d](/filings/0001628280-26-053864.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [105](/filings/0000899715-23-000157.md) | [106](/filings/0000899715-24-000096.md) | [106](/filings/0000899715-24-000119.md) | [106](/filings/0000899715-24-000145.md) | [110](/filings/0000899715-25-000106.md) | [110](/filings/0000899715-25-000125.md) | [111](/filings/0001628280-25-050139.md) | [114](/filings/0001628280-26-029536.md) | [114](/filings/0001628280-26-053864.md) | [115](/filings/0001628280-25-050139.md) | [115](/filings/0001628280-26-029536.md) | [116](/filings/0001628280-26-053864.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 114,878,989 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-053864.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.